Brown, Lisle/Cummings’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$78.4K Hold
355
– – 0.02% 327
2026
Q1
$105K Hold
355
– – 0.03% 281
2025
Q4
$96.9K Hold
355
– – 0.02% 286
2025
Q3
$95.9K Hold
355
– – 0.02% 283
2025
Q2
$97.8K Buy
355
+1
+0.3% +$272 0.03% 271
2025
Q1
$93.9K Buy
354
+2
+0.6% +$493 0.03% 277
2024
Q4
$81.7K Buy
352
+252
+252% +$57.9K 0.02% 285
2024
Q3
$22.1K Hold
100
– – 0.01% 387
2024
Q2
$19.7K Hold
100
– – 0.01% 385
2024
Q1
$21.5K Hold
100
– – 0.01% 368
2023
Q4
$21.1K Hold
100
– – 0.01% 361
2023
Q3
$20K Hold
100
– – 0.01% 336
2023
Q2
$18.5K Hold
100
– – 0.01% 348
2023
Q1
$19.2K Hold
100
– – 0.01% 338
2022
Q4
$16.8K Hold
100
– – 0.01% 332
2022
Q3
$17.7K Hold
100
– – 0.01% 325
2022
Q2
$20.5K Buy
+100
New +$21.2K 0.01% 326

Other funds holding CME

Brown, Lisle/Cummings's CME Position: Q2 2026 in Review

Brown, Lisle/Cummings held its CME Group (CME) position steady in Q2 2026 at 355 shares worth $78.4K. The position accounts for 0.02% of the portfolio, ranked #327.

Brown, Lisle/Cummings first reported a position in CME in Q2 2022 and has held it in 17 quarters since. The position peaked at $105K in Q1 2026. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Brown, Lisle/Cummings held 355 shares of CME Group worth $78.4K as of Q2 2026.
  • Brown, Lisle/Cummings left its CME Group share count unchanged in Q2 2026.
  • CME Group made up 0.02% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #327 holding.
  • Brown, Lisle/Cummings first reported a position in CME Group in Q2 2022 and has held it in 17 quarters since.
  • Brown, Lisle/Cummings's CME Group position peaked at $105K in Q1 2026.
  • 1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.